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General Rheumatology and Soft 
Tissue Rheumatism 
01 New onset painful joints 
02 An acutely swollen/hot joint 
03 Painful shoulders - rotator cuff and frozen shoulder 
04 Tennis elbow and golfer's elbow 
05 Carpal tunnel syndrome and other entrapment neuropathies 
06 Fibromyalgia syndrome 
07 Plantar fasciitis 
PROBLEM 
01 New Onset Painful Joints 
Case History 
June is a 32-year-old tour guide with an eight-week history of painful stiff hands and 
difficulty walking in the mornings. The symptoms usually last for 90 minutes. For the last 
six weeks she has been using diclofenac 50 mg bd with moderate benefit. Her mother has 
rheumatoid arthritis treated with methotrexate. 
What additional history will help to determine a diagnosis? 
What is the relevance of her family history? 
What aspects of the examination will be particularly relevant? 
Which investigations should be performed? 
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Background 
History 
Obtaining a clear history of June's symptoms will assist greatly in narrowing your initial 
differential diagnosis as a prelude to examination and investigations. Open questions 
that encourage the person to start with their initial symptoms provide chronology and 
the pattern of progression. Gentle prompting can, towards the end of consultation, be 
supplemented with specific questions. As you listen to the story, you will be assessing the 
impact of the symptoms on the individual's life and its components of family, work and 
leisure. Specifically: 
• Are symptoms related to a musculoskeletal problem? 
• Was there an identified trigger or precipitant? 
• What has been the pattern or progression of symptoms? 
• Are there features of systemic illness or inflammatory disease? 
• Has anything helped the problem? 
Pain and loss of function are primary presenting symptoms, but do not always coexist. 
Individuals differ in their descriptors of pain, its intensity and its impact. You will be told 
when the problem began and where. Is the pain in a joint; in a related joint structure such 
as tendon, ligament or bursa; or in a bone? What is the nature of the pain; when does it 
occur; and what is the effect of movement? Malignant pain is usually a dull, deep ache 
within a bone, occurring at night or when resting. Similar symptoms may occur with 
Paget's disease or with a fracture. Differentiators of inflammatory from non-inflamma-
tory/mechanical joint pain are summarized in Table 1.1. 
r-'iIl Differentiators of joint pain 
Inflammatory pain Non-inflammatory/mechanical pain 
• Pain and stiffness predominant in morning and at end of day • Short-livedjointstiffness 
• Stiffness greater than 30 minutes • Pain worsens with activity 
• Symptoms lessen with activity • Pain improves with rest 
• Pain does not improve with rest 
• Localized erythema, swelling, tenderness 
• Systemic features - fatigue, weight loss 
Localization of pain requires clarification as to whether symptoms are recreated by 
contact or movement in the area, or whether the pain is referred from another site. 
Referred pain occurs when sensory perception externalizes nociceptive input from the 
sclerotome or myotome of an affected structure to the relevant dermatome. Table 1.2 
shows common referred pain patterns. 
Onset of symptoms following trauma supports mechanical disruption of a joint, dis-
ruption of a joint's surrounding capsule and ligaments, or fracture. Less obvious triggers 
to explore are infections (Table 1.3), vaccinations (Rubella) and recent travel. A tactful 
approach is required when soliciting information on genitourinary symptoms or a 
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Common presentations of referred pain 
Area pa in experienced Origin of pain 
Shoulder Cervical spine 
Bicepsand lateral upperarm Shoulder and rotator cuff 
Groin, inner knee Hip 
Lateral thigh, buttock Trochanteric bursa 
Common infections associated with arthritis 
Viral 
Hepatitis B, C 
Rubella 







* Serology should be tested according to exposure. 
Genitourinary 
Chlamydia trachomotis 
history of a new sexual partner, as it is not obvious to a patient with arthritis as to why 
you would be asking such questions. 
A comprehensive family history is a key part of every clinical history. A familial pat-
tern of a specific diagnosis such as rheumatoid arthritis (RA), ankylosing spondylitis or 
systemic lupus erythematosus (SLE) highlights that diagnosis, and may also raise related 
diagnoses that are particularly relevant for seronegative spondyloarthritides such as pso-
riasis or inflammatory bowel disease. 
Examination 
Examination identifies the pattern and number of joints involved and extra-articular fea-
tures (Table 1.4). Features of inflammation are sought: temperature, pulse and blood 
pressure are measured, and an assessment is made of localized erythema and warmth, 
tenderness, inflammation obscuring the joint margins, and reduced function. You 
should distinguish monoarthritis from oligo arthritis (::0;4 joints) and polyarthritis (>4 
joints), whether these joints are large or small, and whether there is spinal (particularly 
sacroiliac) involvement. Distal to the wrist and ankle there are at least 56 joints, so that as 
the number of joints increases, the greater the probability is of involvement of both 
hands and feet and of the pattern becoming increasingly 'symmetrical'. Fingernails are 
assessed for pitting or onycholysis suggestive of psoriasis. The scalp, umbilicus, natal cleft 
and extensor surfaces of knee and elbow should be inspected. The presence of a malar 
rash or photosensitive rash in a young woman suggests SLE. 
Investigations 
Investigations serve to: 
• Confirm or refute a diagnostic possibility 
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, Patterns of arthritis 
Pattern Monoarthritis Inflammatory Asymmetrical Symmetrical small DIP hands 
spinal disease largejoint joint arthritis 
Sacroiliitis arthritis (MCP, PIP, MTP) 
Differentia I Trauma Ankylosing Psoriatic arthritis RA Inflammatory OA 
diagnosis spondylitis (if involves PIP and 
lstCMC) 
Haemophilia Psoriatic arthritis Reactive arthritis SLE Psoriatic arthritis 
Septic IBD IBD Psoriatic arthritis 
Gout 
Pseudogout 
Further X-ray Review personal Review personal Examine X-ray hands 
investigations and family history and family history rheumatoid nodules 
Aspirate for HLA-B27 Examine for Skin rashes, 
crysta Is and conjunctivitis and serositis or 
culture urethritis, and scalp mucositis 
and buttocks for 
psoriasis 
X-ray lumbar Infection screen Urinalysis 
spine and SI joints RF, CCP antibodies, 
ANA 
X-ray hands 
a nd feet 
ANA, antinuclear antibodies; (CPr cyclic citrullinated peptides; CMe, carpometacarpophalangeal; lJlP, distal interphalangeal; IBU, inflammatory bowel 
disease; MCP, metacarpophalangeal; MTP, metatarsophalangeal; OA, osteoarthritis; PIP, proximal interphalangeal; RA, rheumatoid arthritis; RF, 
rheumatoid factor; SI, sacroiliac; SLE, system ic lupus erythematosus. 
• Monitor for known complications of the disease process or proposed treatment 
• Document a parameter that changes with disease activity or treatment 
The latter includes the inflammatory markers erythrocyte sedimentation rate (ESR) 
and C-reactive protein (CRP), which are non-specific markers. Whenever the possibility 
of a septic joint is considered, obtaining aspirate and culture from the joint is mandatory. 
Aspirated fluid is collected into a sterile container and an ethylenediaminetetraacetic acid 
(EDTA)-containing tube to enable a cell count, and is sent with a request for Gram stain-
ing, polarized light microscopy, culture and sensitivity, and cell count and differential 
cell count. If there will be a significant delay in the sample reaching the laboratory, fluid 
can be inoculated into a blood culture system. 
The early signs and symptoms of RA are not always typical. RA is characterized as 
autoimmune partly on the basis of the presence of rheumatoid factor (RF), an autoanti-
body (usually immunoglobulin M [IgMJ) targeting the Fc portion ofIgG. Its sensitivity is 
low, ranging from 60%-80%, and specificity is lower, the antibody being frequently pre-
sent in other connective tissue diseases, which limits the diagnostic utility. 
Recent Developments 
~ RF is present in 70% of RA cases but is not specific, occurring in 5% of healthy individuals, and globally is more associated with chronic infection than rheumatic 
diseases. Non-RF antibodies were first described in the 1960s, with the target 
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epitopes now identified as citrulline residues, which are arginine residues 
modified by peptidylarginine deaminase (PADI). Assays are now available for the 
detection of antibodies to cyclic citrullinated peptides (anti-CCP antibodies), 
which are highly sensitive and specific for RA and are a poor prognostic marker 
of joint erosion, vasculitis and rheumatoid nodules. ' The specificity of anti -CCP 
in RA is >90% with sensitivity of 33%-87%. When combined with IgM-RF, anti-
CCP has positive predictive value of >90% for RA.2 A study of undifferentiated 
polyarthritis found that 93% of subjects positive for anti-CCP at first clinic visit 
progressed to RA compared to 25% who were anti-CCP negative.3 
2 Smoking increases the risk of RA 2-4 fold and also influences the manifestations 
of the disease - with increased RF positivity and erosive disease, nodularity and 
vasculitis - similar to the findings noted with anti-CCP antibodies. Smoking may 
break immune tolerance by creating neo-epitopes on IgG and thus leading to RF 
development. Recent work has shown that smoking is associated with increased 
citrullination. The subsequent citrullinated antigens bind with more affinity to 
the HLA-DR4 shared epitope subtypes, leading to increased risk of RA.4 
Conclusion 
Persistent arthropathy in a younger patient necessitates both accurate diagnosis and 
effective management. A working knowledge oflocal infectious triggers is required, with 
supplemental knowledge of the likely pathologies based on age and gender. History and 
examination need to include potential exposure to infectious triggers, along with per-
sonal and family history. Examination will confirm or exclude significant joint inflam-
mation, and provide information on its pattern and severity (number of joints and 
functional impact). Targeted investigations will narrow the diagnosis, with the urgent 
investigation being exclusion of septic arthritis if there is clinical suspicion. 
Further Reading 
2 
Mimori T. Clinical significance of anti-CCP antibodies in rheumatoid arthritis. Intern Med 
2005; 44: 1122-6. 
Schellekens GA, Visser H, De Jong BAW et al. The diagnostic properties of rheumatoid arthri-
tis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43: 155-63. 
3 van Gaalen FA, Linn -Rasker SP, van Venrooij WJ et al. Autoantibodies to cyclic citrullinated 
peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: 
a prospective cohort study. Arthritis Rheum 2004; 50: 709-15. 
4 Gorman JD. Smoking and rheumatoid arthritis: another reason just to say no. Arthritis Rheum 
2006; 54: 10-13. 
